Powder: -20°C for 3 years
In solvent: -80°C for 2 years
MAFP is an effective irreversible inhibitor of anandamide amidase. MAFP is an active-site directed and irreversible inhibitor of cPLA2 and iPLA2.
Description | MAFP is an effective irreversible inhibitor of anandamide amidase. MAFP is an active-site directed and irreversible inhibitor of cPLA2 and iPLA2. |
In vitro | In a concentration-dependent manner after a 5 min preincubation at 40°C in P388D1 cells, MAFP inhibits iPLA2 (IC50: 5 μM). MAFP is also an inhibitor of anandamide amidase and as a ligand for the CB1 cannabinoid receptor. MAFP shows selectivity towards anandamide amidase for which it is approximately 3000 and 30000-fold more potent than it is towards chymotrypsin and trypsin, respectively. cPLA is a phospholipid hydrolase using the hydroxyl of serine-228 residue as its catalytic nucleophile[1]. MAFP displaces [3H]CP-55940 binding to the CB1 cannabinoid receptor with an IC50 of 20 nM vs 40 nM for anandamide[2]. |
Synonyms | Methyl Arachidonyl Fluorophosphonate |
Molecular Weight | 370.48 |
Formula | C21H36FO2P |
CAS No. | 188404-10-6 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Methyl Acetate: 9.0 mg/mL (24.3 mM)
DMSO: 90.0 mg/mL (242.9 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MAFP 188404-10-6 其他 Others Methyl Arachidonyl Fluorophosphonate Inhibitor inhibitor inhibit